LAS VEGAS -- Event-free survival (EFS) in high-risk non-muscle invasive bladder cancer (NMIBC) improved significantly when patients received the PD-1 inhibitor sasanlimab in addition to bacillus ...

Researchers at City of Hope will present more than 74 chaired, plenary, educational, minisymposium, poster and other sessions on innovative clinical trial results, breakthrough diagnostic techniques ...

Background: Clinical experience suggests that many women with triple-negative metastatic breast cancer (MBC) relapse quickly. This has implications for clinical practice and trial design.

Pathfinder Award winners were announced Friday, spotlighting talented and committed high school seniors from Palm Beach and ...

Q1 2025 Earnings Call Transcript May 1, 2025 Alkermes plc misses on earnings expectations. Reported EPS is $0.13 EPS, expectations were $0.28. Operator: Greetings, and welcome to Alkermes’ First ...

AI agents are gaining traction, but building them to be useful, governable and grounded in real business data remains a challenge. That's why KNIME, the open source data analytics and AI company, ...

It makes sense that a man who yearns for a reality untroubled by other humans would be drawn to art that is untouched by ...

The American Association for Cancer Research (AACR) will honor the following cancer researchers and physician-scientists during the AACR Annual Meeting 2025, to be held April 25-30 at the McCormick ...

Entera continued to generate intrinsic value with progress across our programs while significantly extending our cash runway into late 2026 via direct investment from marquis investors and our ...

Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ETCompany ParticipantsLavina Talukdar - Senior Vice President, ...

Over 100 cars, trucks, 50/50 drawing, food trucks, and music by DJ Don from Cruisin Orlando. Sponsored by City of Longwood. 5-8 p.m. May 10, Longwood Historic District, Church Avenue, Longwood, free.

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business ...